Skip to main content

Table 2 Numbers of patients showing metastasis at various sites

From: Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer

Site of metastasis

Group A* (n = 24)

Group B** (n = 30)

Axillary lymph node

22 (91.7%)

7 (23.3%)

Extra-axillary lymph node

7 (29.2%)

13 (43.3%)

Bone

4 (16.7%)

9 (30%)

Liver

1 (4.2%)

2 (6.7%)

Lung

3 (12.5%)

4 (13.3%)

Pleural dissemination

0 (0%)

1 (3.3%)

  1. *Group A: Cases found to have metastases at the initial presentation.
  2. **Group B: Cases found to have newly diagnosed metastases at some point after a surgery.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us